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ABSTRACT

Olfactory function declines throughout the different stages of kidney disease. End-stage
renal disease (ESRD) patients have experienced improved olfactory function after dialysis,
leading some researchers to suspect uremic toxins as the cause of olfactory decline (Raff et al.,
2008; Bomback & Raff, 2011). It is thought that p-cresol is the specific uremic toxin to cause a
decline in olfactory function because it is not easily filtered out of the blood during dialysis
(Meijers et al., 2010). The study sought to set up a control group for future studies by
demonstrating p-cresol is not in the blood of healthy participants and to collect normative values
for an olfactory threshold test. Results supported the hypothesis that p-cresol is not present in the
blood of healthy participants, which strengthens the idea that p-cresol may be the cause of
olfactory dysfunction in ESRD patients.
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CHAPTER I
INTRODUCTION AND BACKGROUND

Studies have examined olfactory identification and detection in special populations
including Alzheimer’s disease, Parkinson’s disease, and kidney disease. These populations have
been studied to investigate differences in olfactory function between the healthy population and
disease population in question. Additionally, researchers have sought to determine whether
different measures of olfactory function can pin point what stage of the disease a person is in, or
if different olfactory measures can be used to predict whether individuals might develop a certain
disease (Huttenbrink, Hummel, Berg, Gasser, & Hahner, 2013).
The kidney disease population has been studied extensively with researchers
investigating both the presence of olfactory identification and detection deficits as well as how
they relate to nutrition/health status and timing of dialysis (Griep et al., 1997; Raff et al., 2008).
Many of these studies have found evidence supporting the idea that the end-stage renal disease
(ESRD) population experiences olfactory deficits in both identification and detection; however,
they have not identified when olfactory deficits occur during the progression of the disease or
what causes these deficits (Bomback & Raff, 2011).
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Background
Chronic Kidney Disease
Stages of the Disease. Chronic kidney disease (CKD) is a condition in which the kidney
is either damaged or experiences decreased function for at least three months. A person’s
kidneys with this disease can no longer clean out toxins and waste from the blood or carry out
normal functions such as regulation of blood pressure, water, and important chemicals (Levey et
al., 2003). CKD has its etiology based in various health problems, such as high blood pressure,
diabetes, chronic kidney infections, and numerous other genetic and external causes. The
person’s kidneys do not suddenly cease to work, but rather decline in function throughout an
extended period of time, as identified by the five stages of CKD (Levey et al., 2003). The fifth
stage of CKD is typically referred to as end-stage renal disease (ESRD) and is classified as the
person’s kidneys only functioning at <15% normal capacity (Levey et al., 2003). However,
ESRD is used to indicate that a kidney disease patient is being treated with dialysis or is
considered for transplantation, regardless of what stage of CKD the patient is in (Levey et al.,
2003). Once a person is given the classification of ESRD, he/she must begin dialysis in order for
his/her kidneys to regain some functionality, but remains dependent on the procedure in order
live.

Comorbidities and Olfactory Function. ESRD patients do not generally have only
ESRD, but instead multiple health problems including diabetes, hypertension, depression, and
sleep disorders. These comorbidities have been studied with each other, independent of ESRD,
2

with olfactory function being one of the most common problems, for example in diabetes and
depression. Researchers have recently found that diabetes, specifically the use of insulin, affects
olfactory function in adult mice (Aime et al., 2012). Insulin’s role in olfactory function has yet to
be completely determined, but the researchers of this particular study found that the injection of
insulin decreased olfactory detection in the mice. One possible explanation for this phenomenon
is insulin’s role in eating habits. Insulin interacts with the olfactory bulb in order to let the animal
know when it is satiated to prevent over eating (Aime et al., 2012).
One study by Ketterer et al. (2011) examined the role of insulin on olfactory function. All
participants fasted ten hours before testing began and some participants volunteered to receive
insulin while the control group did not receive insulin. The participants who received insulin had
higher olfactory threshold values, indicating higher insulin levels reduce olfactory function.
Another study conducted by Stafford and Welbeck (2011) found that participants who were
satiated had higher threshold scores compared to those who were not satiated. Because insulin
levels increase after eating, the authors suggest that insulin levels are a very plausible factor in
olfactory function.
Depression is also linked to olfactory function in many ways, including its interactions
with the olfactory bulb as well as other parts of the brain. Several areas of the brain involved in
olfactory function processes are used in emotional processes as well. The piriform, orbitofrontal,
and insular cortex have been found to be part of human odor perception (Zattore et al., 1997).
Zald and Pardo (1997) also found the amygdala is activated when presented with an aversive or
novel odor. The orbitofrontal cortex participates in the processing of emotional information
(Pardo et al., 1993) and the insula is activated during the experience of negative emotions (Lane
3

et al., 1997). The amygdala plays a role in encoding positive and negative emotions and has been
found to only be activated during negative emotions (c.f. Pause, Miranda, Goder, Aldenhoff, &
Ferstl, 2001). It has also been found that there is abnormal activation of the amygdala and
orbitofrontal region in depressive patients (Drevets et al., 1992). These findings suggest a
possible link between depression and olfactory function.
In one study, (Negoias et al., 2010), olfactory bulb volume was found to be smaller in
patients with major depressive disorder (MDD) compared to control groups. Scores on Beck’s
Depression Inventory were negatively correlated to olfactory bulb volume and olfactory
sensitivity. Other studies have found that MDD patients have reduced odor perception (Pause,
Miranda, Goder, Aldenhoff, & Ferstl, 2001) and decreased odor identification (Gross-Isseroff et
al., 1994; Serby, Larson, & Kalkstein, 1990), further supporting the idea that olfactory function
is correlated with depression. Complete loss of olfactory function or distortion of perceived
smells has been studied in relation to depression. Smeets et al. (2009) found that patients who
experienced parosmia (experiencing a different perceived odor from what the actual smell is) as
well as anosmic patients were more likely to experience depression. Even though depression has
been predominantly correlated with odor detection and identification, perceived pleasantness or
liking of an odor has been shown to change with the presence of depression (Satoh et al., 1996).
This may be caused by alterations in brain structures, such as the amygdala, that processes
pleasant and unpleasant emotions and perceives aversive or novel odors. Changes in the
amygdala due to depression may cause the perception of an odor to a patient to change and be
experienced differently from a person with a normal amygdala.

4

These studies point to the possibility that comorbidities cause olfactory dysfunction in
ESRD patients as the rates of depression and diabetes are higher in ESRD patients. The
prevalence of depression in the ESRD population is thought to range from 20-30% (Chilcot,
Wellsted, Silva-Gane, & Farrington, 2008; Kimmel, Cukor, Cohen, & Peterson, 2007) while the
rate of diabetes is 35-55% in the ESRD population (U.S. Renal Data System). Because most
ESRD patients have one of these comorbidities, there is a possibility that olfactory dysfunction is
caused by an interaction of the different diseases.

Olfactory Function in ESRD. Griep et al. (1997), while studying ESRD patients, wrote
that odor perception is one of the most important aspects of life. Odor perception leads to
appreciation of different types of food, detection of possibly dangerous elements, and overall
quality of life. Thus, impaired olfaction sensitivity represents a significant loss.
One of the first studies of impaired olfactory function in the ESRD population was
conducted by Schiffman, Nash, and Dackis (1978). They found that compared to a young normal
control group, chronic renal failure patients had decreased odor discrimination and rated odors as
more unpleasant. Possible reasons for impaired olfactory function according to these authors
include: 1) the removal of nutrients through dialysis may inhibit the quick regeneration of cells
in the olfactory epithelium 2) Vitamin B12 deficiency and peripheral neuropathy may slow down
nerve conduction velocities and 3) psychological defense mechanisms may decrease the ability
to discriminate odors among the ESRD population (Conrad et al., 1987; Griep et al., 1997). In a
subsequent study, Corwin (1989) confirmed that ESRD patients’ odor discrimination was
impaired compared to control groups. In addition, Corwin (1989) found ESRD patient’s odor
5

discrimination scores to be lower after treatment with dialysis. These findings suggest a fourth
theory against the argument that impaired olfactory function is caused by a buildup of uremic
toxins. Other studies have found olfactory identification ability to be lower in ESRD patients and
to fall by an estimate of 5% between pre and post-dialysis, further enforcing the idea that
olfactory function impairment is not due to uremic toxin buildup given that dialysis does not help
(Conrad et al., 1987).
On the other hand, Griep et al. (1997) found a positive correlation between creatinine
clearance and smell perception, indicating that olfactory function may be tied to uremic toxin
levels. However, the correlation between creatinine clearance and smell perception was found in
patients not undergoing dialysis. This finding is similar to Corwin’s in that dialysis was not
responsible for improvement in olfactory function. One explanation is that it may take days for
olfactory function to become normal after urea concentrations are lowered (Griep et al., 1997).
Another explanation is that the olfactory system has a lower threshold for uremic toxins and thus
cannot be completely repaired but rather only slightly improved because the levels of uremia are
above its threshold (Owen, Lew, Liu, Lowrie, & Lazarus, 1993). Further findings from Griep et
al.’s (1997) study demonstrated a negative correlation between both uremia and serum
phosphorus and smell perception, supporting the theory that uremic toxins may play a role in
olfactory function impairment in this group. The uremic toxin argument is further supported by
the complete recovery of olfactory function in kidney transplant patients, indicating that the
complete clearance of the uremic toxins allowed for olfactory function to return (Griep et al.,
1997). Raff et al. (2008) also found no correlation between retained uremic molecules and
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olfactory function, but speculated that there may be other small uremic toxins in play and that the
relationship between impaired olfactory function and uremic molecules is complex.
Malnutrition has become a topic of interest among the ESRD population because it
affects up to 75% of ESRD patients (Raff et al., 2008). Several factors contribute to the
development of malnutrition, including poor oral hygiene, gastrointestinal complications of
comorbid diseases, increased levels of inflammatory cytokines, changes in tryptophan, serotonin,
ghrelin, and leptin levels, and increased levels of middle molecules and indoles (uremic toxins)
(Raff et al., 2008). Recently malnutrition has been related to olfactory function impairment in the
ESRD population. Raff et al. (2008) compared the olfactory function of 31 hemodialysis patients
to their nutritional scores determined by the Subjective Global Assessment (SGA) score and
retained uremic molecules. They found that lower SGA scores were inversely correlated with
smell scores from the University of Pennsylvania Smell Identification Test (UPSIT) (Doty,
Shaman, Kimmelman, & Dann, 1984), that the healthiest of the ESRD group was comparable to
the control group’s scores, but the ESRD patients with lower SGA scores scored lower on the
UPSIT, showing that nutritional status relates to olfaction. Thus, a fifth theory explaining
olfactory sensitivity impairment in ESRD patients is lack of essential nutrients to build proteins,
in other words, malnutrition.

Measurement. Measurement of olfactory sensitivity in ESRD patients may be a factor
influencing the differing outcomes. Olfactory identification relies more on verbal labeling than
olfactory sensitivity. Although the participant may be able to smell the odorant, they may not be
able to put a name to it, leading the participant to guess. If the participant guesses wrong on an
7

identification test, it indicates that their olfactory function is low compared to the normative
values. This may skew results in multiple ways. First, children do not have large vocabularies
and may not be able to name certain odorants; thus their odor processing abilities may be
underestimated. Also, women tend to outperform men on olfactory identification tests (Doty &
Cameron, 2009). This may be due to verbal memory rather than actual olfactory function.
Threshold tests can control for verbal memory because they do not rely on the participant to label
an odorant, but rather tell whether or not an odorant is detected. By using threshold tests,
researchers can also obtain the specific concentration at which someone can detect an odorant,
compared to an identification test where it is all or nothing.
Children who were diagnosed with chronic kidney disease did not score differently on an
olfactory identification test from the control group and healthy group, indicating that olfactory
function did not relate to renal failure (Armstrong, Laing, Wilkes, & Kainer, 2010). However,
the researchers stated that the outcome may have been different if they tested detection
thresholds or intensity instead of only identification.
Landis et al. (2011), using both a threshold test containing n-butanol and acetic acid and
Sniffin’ Sticks, an identification test, measured olfactory function of dialysis patients before and
after dialysis. Compared to control groups, olfactory threshold and identification were worse in
dialysis patients. When threshold scores and identification scores were examined before and after
an hour of dialysis, it was found that overall scores improved. Identification scores of the dialysis
patients were similar to the control group’s scores. However, the acetic acid threshold values,
although improved after dialysis, were not comparable to the control group scores, and the
threshold values for n-butanol remained unchanged before and after dialysis. Given the
8

contradictory information about the role of uremic toxins on olfaction in the ESRD population,
the authors suggest that more than one dialysis treatment is needed in order to improve olfactory
function.

Role of Uremic Toxins. There are many uremic toxins that play a role in ESRD
including p-cresol, creatinine, and urea (Vanholder et al., 2003). Uremic toxins are chemicals
normally filtered out by healthy kidneys, but once the kidneys decline in function, the toxins
build up in the body and interact negatively with biological functions of the body (Vanholder et
al., 2003). Uremic toxins have been examined for their effects on mortality rates and nutrition,
but not on their effects in olfactory function (Campbell, Bauer, & Johnson, 2012; Meijers et al.,
2010; Raff et al., 2008).
Researchers began focusing on p-cresol due to its relationship with mortality rates in the
ESRD population as well as the poor clearance rate of the toxin (Lin et al., 2011; Meijers et al.,
2010). In one study, researchers found evidence of p-cresol binding to multiple proteins, leading
to the prevention of other vital molecules or even medications binding to proteins. It was also
found that p-cresol inhibited the production of leukocytes which led to decreased infection
prevention (De Smet, 2003). Multiple studies have confirmed that p-cresol binds to proteins and
comes in two forms: free and bound, indicating whether or not it is bound to a protein. The
chemical name and molecular weight changes between the two forms, but there has been a
debate about whether or not there is a difference in the clearance rate during dialysis between the
two. Niwa (1993) found that both forms of p-cresol are harder to clear and reduce in dialysis
patients. Other studies have confirmed this finding, suggesting that p-cresol is harder to clear in
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general because of the kidney’s inability to separate p-cresol from the proteins (Dobre, Meyer,
Hostetter, 2013).
Since low molecular weight is the possible cause for decreased filtration rate of p-cresol,
studies have begun focusing on different techniques for filtering out the toxin. Lessafer et al.
(2000) looked at high and low flux filters to examine if there would be a difference in filtration
rate of p-cresol. Although the researchers assumed there would be a difference between the
filters since each one is used for specific sizes of uremic toxins, no difference was found
(Lessafer et al., 2000). Two studies focused on different types of dialysis and their effects on
filtration of p-cresol. The results indicated p-cresol was cleared out significantly better with
hemodialysis versus peritoneal dialysis, but the researchers still noted that p-cresol is not cleared
out nearly as well as other uremic toxins (Karkar, 2012; Pham et al., 2008). Kreiter et al. (2009)
examined the differences in clearance rate using two filters as well and found no difference.
However, they also examined the clearance rate of p-cresol after dialysis and filtration and
noticed that despite a marked improvement, these processes did not even reach 50% clearance
rate of p-cresol. Multiple studies have confirmed these results and authors are beginning to agree
that p-cresol is very difficult to clear out of the kidneys efficiently and a better technique for the
removal of the toxins needs to be developed (Davenport, 2011; Lee et al., 2010; Martinez et al.,
2006).
Although debate continues about how to better clear p-cresol from ESRD patients’
kidneys, one study has focused on a different approach to the problem. Nakabayashi et al. (2011)
examined ways to treat intestinal problems within the ESRD population. The authors
hypothesized that phenol levels and p-cresol levels in the body affected bowel movements of the
10

patients and that one way to treat this problem would be through the use of synbiotics
(Nakabayashi et al., 2011). Although the sample size was small (N=7), they found that the use of
synbiotics not only improved bowel movements of the patients, but also decreased the serum pcresol level. This finding suggests that there may be a solution to the build-up of p-cresol in
ESRD patients that can be paired with dialysis in order to improve overall kidney health.
The majority of studies involving p-cresol in the ESRD population have focused on the
levels of p-cresol present in either free or bound form as well as the filters that are used during
dialysis. Although these studies have provided an abundance of information that can be used to
improve upon the filters currently being used, not many studies are focusing on how to reduce
the level of p-cresol in the body by other means, with the exception of the study of synbiotics
(Nakabayashi et al., 2011).

Olfactory Binding Proteins
Olfactory binding proteins (OBPs) are low molecular weight proteins that are found in
nasal mucus of various species (Pelosi, 1994; Pevsner, Hou, Snowman, & Snyder, 1990).
Although advances have been made about the functions of OBPs, the function of these proteins
is still not completely known. Many studies have focused predominately on insect OBPs, but
there are studies beginning to investigate the role of these proteins in mammals, a few including
humans (Steinbrecht, 1996). In humans, there is evidence of two different types of OBPs: OBPA and OBP-B (Briand et al., 2002). The roles of these specific OBPs are not completely
understood, but studies suggest that they carry odorants, specifically lipophilic odorants, across
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the epithelium in order to be detected by olfactory receptor neurons (Briand et al., 2002; Pevsner,
Hou, Snowman, & Snyder, 1990).
Bomback and Raff (2011) have suggested that uremic toxins may play a role in damaging
the olfactory epithelium (which could play a role with OBPs) and other higher order olfactory
structures, causing olfactory dysfunction. These results further add to the hypothesis that
olfactory dysfunction is directly related to kidney disease.

Purpose of the Study
As the cause of olfactory dysfunction in the ESRD population remains unknown, this
pilot study was designed to set up a control group for future olfaction studies in the ESRD
population. Raff et al. (2008) and Bomback and Raff (2011) along with many other researchers
have suggested the possibility of uremic toxins playing a role in olfactory dysfunction. As pcresol is one of the most noted of the unfiltered toxins, it made sense to examine it.
One of the first goals is to determine whether or not p-cresol is present in general, healthy
people. Since p-cresol is only studied in relation to ESRD, not many studies explicitly state
whether or not p-cresol might still be present in healthy people, just in lower amounts. In order to
determine if p-cresol is the cause of olfactory dysfunction, it must be shown that healthy people
do not have it. If healthy people with normal olfactory function also have p-cresol, then other
factors in addition to the amount of p-cresol might be at play in the ESRD population. It is
hypothesized that healthy people will not have p-cresol in their blood.
The second goal is to determine threshold values of the healthy population using a new
threshold test. Because the one commercially available threshold test does not include an odorant
12

for p-cresol nor for vanillin, which shares a similar chemical structure, a new threshold test and
procedure, the Wheeler-University of Tennessee at Chattanooga (WUTC) threshold test (Tewalt,
2012) was developed. ESRD patients should not even be able to detect this p-cresol because it is
already present in their system. It is hypothesized that p-cresol may be taken up by OBP-As in
humans for transport to the olfactory epithelium. If this is the case, an odorant similar to p-cresol
will be transported in the same manner. Vanillin is similar to p-cresol in that it is hydrophobic,
has a benzene ring, and is a very detectable odorant at high concentrations, hence its selection as
one of the test odorants (Appendix D). Thus, the second hypothesis is that threshold values for
p-cresol and vanillin will be similar, thus having a positive correlation. These values will then be
used as a base of comparison for the ESRD population.
Given that p-cresol is thought to take up OBPs, and molecules similar to it would be
transported in the same way, p-cresol may block the detection of vanillin. If both p-cresol and
vanillin use the same OBPs, the detection of one odorant may use all of the OBPs, leaving no
more for the detection of the second odorant. The third hypothesis is that smelling p-cresol will
block the detection of vanillin.
Finally, the fourth hypothesis is that there will be no correlation between p-cresol and
threshold values. Even though p-cresol is hypothesized to influence olfactory function, healthy
people should not have p-cresol in their blood. Because it is also hypothesized that healthy
participants’ blood samples will not contain p-cresol, it follows that no correlation will be found.
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CHAPTER II
METHODS

Participants
The sample consisted of 15 students from The University of Tennessee at Chattanooga.
Ten participants (67%) identified as Caucasian, 4 (27%) as African-American, and 1 (6%) as Biracial. Participants included 7 females and 8 males with age of participant ranging from 18-24.
The mean age of the participants was 19.86 (SD=1.66). Out of the participants, one was currently
smoking and four had smoked previously, but not currently. Participants were recruited from
introductory psychology courses as well as upper level classes in psychology and chemistry, and
were given extra credit at the discretion of the instructor for their participation. Although
multiple medical disorders and medications were listed on the demographics questionnaire, only
a few were present in this sample: one participant had thyroid disorder, five had asthma, two had
lung trouble, one had a broken nose, one had anemia, two had a history of concussions, two had
food allergies, four had sinus problems, ten had seasonal allergies, two had medical allergies.
Participants taking medications were as follows: two taking anti-inflammatories, one taking
antihistamines, and one taking stimulants.
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Measures
Blood Analysis. Students from the Chemistry department at UTC were recruited in order
to analyze the blood samples, per IRB and Blood Assurance regulations. The instruments used to
analyze the blood samples included a Centrifree Micropartition to centrifuge samples, a
ThermoFinnigam UV1000 SpectraSystem High Performance Liquid Chromatography (HPLC),
columns for the HPLC, and a ThermoFinnegan Polaris Q Mass Spectrometer equipped with a
Direct Probe Controller (De Smet et al., 1998).

Demographics Questionnaire. A demographics questionnaire was used to collect
medical information from the participants. The questionnaire asked for age, ethnicity, gender,
and level in college of the participants. Questions also included how often, if ever, the
participants engaged in smoking and whether or not participants had a medical condition listed
on the questionnaire (see Appendix C).

Wheeler University of Tennessee at Chattanooga Threshold Test. The WUTC
(Tewalt, 2012) was used in order to measure the participants’ olfactory sensitivity. The test
consists of five odorants including vanillin, pinene, ethanol, isoamyl acetate (banana), and pcresol. The test is double-blinded and randomized in order to prevent researcher bias as well as
desensitization to the odorants. Along with randomization, each odor is presented twice
throughout the test in order to obtain reliability/internal consistency. Blanks are also used in
order to obtain a measure of false positives because false positives can be correlated to
sensitivity as well as possible exclusion criteria.
15

Vanillin and P-cresol Tubes. Two tubes were used to present vanillin and p-cresol to the
participants in order to investigate the possibility of p-cresol preventing vanillin from being
detected. P-cresol was always presented first followed by vanillin. Both tubes were equal in
concentration in order to control for intensity. The answer choices for participants to choose
from in order to identify the odor in the second tube were as follows: peanut, lavender, vanilla,
and black pepper, with vanilla being the correct answer.

Procedures
Protection of Health Information. Before beginning the project, all researchers
involved in the project were required to take the CITI and NIH certification tests. These tests
involve HIPPA training and researchers who take these tests in turn become HIPPA certified.
With these certifications, the researchers were able to handle the health information on the
participants’ demographic questionnaires.

Blood Samples at Blood Assurance. Blood Assurance of Chattanooga agreed to draw
10 mL of un-centrifuged blood from participants of the study as long as the participants donated
blood during the process. Specific dates were chosen in coordination with representatives at
Blood Assurance for participants to donate blood and the extra 10 mL vial. Participants were
then instructed via their professors to go to Blood Assurance on the designated dates to donate
blood and the additional 10 mL vial.
Researchers on the olfactory research team set up a table at Blood Assurance for
participants to sign in and read over the informed consent form (Appendix A). While going over
16

the informed consent form, the participants also signed up for a time to participate in the
threshold test. The researchers explained that the participants’ names would not be put onto the
blood vials. A sticker with a serial number was placed on both the blood vial and the
participants’ informed consent forms in order to link the threshold test results to the blood
samples. After the threshold test and blood sample data were put together, the sticker on the
informed consent form was destroyed in order to protect confidentiality. After participants were
given a vial, participants were then instructed to go to the front desk and sign in for a normal
blood donation. The participants were taken to a private room to answer questions and undergo a
screening process, per Blood Assurance procedures. During the blood donation, the nurses drew
the extra vial of blood for the study and placed the vials in an insulated, properly marked box. At
the end of the day, the blood was stored in a refrigerator set to 4 degrees Celsius in the
biochemistry lab at the Chemistry Department for analysis.

Blood Analysis. The blood analysis occurred in several steps. The first step was
centrifuging one milliliter of each sample in order to run in the HPLC. The samples were first
dissolved in HPLC-water before being run in the HPLC. Once the columns used in the HPLC
were cleaned for five minutes using methanol, the samples were run for 18 minutes in order to
separate out different samples for further testing. Once the samples were filtered out, they were
run in a Mass Spectrometer in order to determine the molecules present in the samples.
Researchers then examined mass spectrum results in order to determine the molecules present in
the samples. Specific details of the procedures used for the blood analysis can be found in
Appendix E written by one of the principal investigators, Dr. Santiago.
17

Threshold Test. Participants arrived at the administration room the day they indicated on
the sign-up sheet that was provided at Blood Assurance. One of the two assigned researchers
went over the informed (Appendix B) consent with the participant. Once the participant
completed the demographics questionnaire (Appendix C), the researcher began administering the
threshold test.
Two researchers were in charge of administering the test. In order for the test to be
double-blind, the first researcher handed the tube to the second researcher. The second researcher
was in charge of holding the tube under the participant’s nose for three seconds. Once the
participant responded “yes” or “no” to whether or not they detected an odor from the tube, the
first researcher recorded the response and handed the second researcher another tube. Each tube
was assigned a number and the order of presentation was generated by a computer and printed
for the first researcher to follow.
In order to prevent contamination of the test with external odorants, the researchers wore
latex free, powder free gloves. The researchers also kept all odorous objects (e.g., food) out of
the testing room at least one hour prior to testing time.

Vanillin and P-cresol. Once the participants completed the threshold test, they were
asked to complete the final part of the threshold test, which including smelling two tubes. The
researcher told the participant that two tubes would be presented, one immediately after the
other, and to indicate on a sheet “yes” or “no” if they detected an odor in the second tube, and if
so, to identify the odor by picking one of the four choices provided. The researcher then held the
first tube (p-cresol) under the participant’s nose for five seconds and immediately switched the
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tubes and presented the second tube (vanillin) for five seconds. Vanillin was never presented first
due to difficulty in labeling/describing p-cresol on the multiple choice answers. Participants then
circled “yes” or “no” on the sheet and picked an answer, from four choices, on the sheet
regarding the odor of the second tube. The four choices were presented in random order for each
participant and included Black Pepper, Peanut, Lavender, and Vanilla, based on answer choices
provided in the UPSIT.
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CHAPTER III
RESULTS

Blood Analysis
In order to determine the presence of p-cresol, mass spectrometry was performed for each
sample collected from the HPLC. Molecular weights on the mass spectra were examined for
each blood sample at different times within two minutes to determine which molecules were
present. Molecular weights up to 300 amu were examined (Figure 1). The data showed that
possible remnants of p-cresol were present in the samples, but at extremely low quantities. Other
amino acids that have similar molecular structures to p-cresol were present in higher quantities:
tryptophan, tyrosine, and phenylalanine.
Because there were only possible remnants of p-cresol, and not positive identifications of
the molecule, it was determined that p-cresol was not present in the blood. This conclusion was
further strengthened by the fact that these remnants were in extremely low quantities.
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Figure 3.1 Example of Mass Spectrum Data

Threshold Test
In order to obtain participants’ threshold values, logistic regression was used. This type
of analysis was chosen due to the nature of the threshold test. Because the test was randomized
and each tube presented twice, the logistic regression allowed for both presentations to be taken
into account. The thresholds for each participant varied between odorants (Table 1). The scores
are interpreted as follows: the higher the threshold value, the worse the participant’s sensitivity
to that odor. However, the threshold values represent predicted threshold values, which are the
predicted concentrations of the odorant the participant would be able to detect. Multiple
interactions were examined using the threshold values. Reliability estimates were not run due to
the small sample size.
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Gender and Ethnicity. Relations between gender and threshold values as well as
ethnicity and threshold values were examined. In order to examine this and other analyses
involving the threshold values, simple regressions were used rather than t-tests due to the
extreme variation in threshold values. There were no significant interactions between threshold
values and gender or threshold values and ethnicity.

Medical Conditions. Simple regressions were run to examine relationships between
medical history and threshold values. Only medical histories that had three participants in the
category were examined due to such a small sample size: asthma, seasonal allergies, and sinus
problems. There were no significant relations for each medical condition when examined with
each separate odorant on the threshold test. When controlling for all three variables, no
significant relationships with the threshold values were found.

Threshold Value Relationships. In order to test the hypothesis involving the
relationship between threshold values for p-cresol and vanillin, Pearson r correlations were used.
The results for the correlation between threshold values for vanillin and p-cresol were not
significant. The relationship between threshold values for vanillin and ethanol was significant
(r=0.887, p<0.001). The relationship between threshold values for isoamyl acetate and how
many blanks were hit was also significant (r=-0.606, p=0.017). All other correlations between
threshold values were not significant.
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Vanillin and P-cresol Tubes
One participant was excluded from the results of the tube presentations due to a peanut
allergy. Although peanut was not presented, it was one of the answer choices. Out of the
remaining 14 participants, only one was not able to smell vanillin.

Table 3.1 Threshold Values for Participants
Participant

Vanillin

Pinene

Ethanol

Isoamyl
Acetate

P-cresol

Blanks

1

.00

187.93

563.16

11219.73

1415.32

0

2

10.68

125.14

.00

1384.43

240.13

9

3

14.60

.04

6008.61

3978.87

.97

9

4

15.00

58.37

323196.34

3753.29

33.77

7

5

15.83

81.28

.00

1384.43

73.91

7

6

44.19

124.86

211.70

5529.37

59.61

6

7

63.80

4977.02

28.47

11048.20

1429.61

1

8

65.20

357.57

604.02

5529.37

706.86

4

9

88.49

150.48

38.01

5445.13

706.86

0

10

114.60

250.03

26594.80

2766.57

706.86

2

11

176.49

179.53

17.06

7815.99

706.86

0

12

178.27

362.45

1.10

5516.61

7396.55

0

13

337.74

457.94

.71

11049.25

2172.85

0

14

352.14

277.97

19.54

5529.37

499.59

2

15

3460.11

14.90

715024.61

1888.10

348.11

1

Note: Thresholds for each participant are ranked lowest to highest based on vanillin
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CHAPTER IV
DISCUSSION

The purpose of the study was to investigate the presence of p-cresol in the healthy
population and to examine the relationship of p-cresol to olfactory threshold values. As
hypothesized, no p-cresol was detected in the blood of the participants. Because this hypothesis
was supported, the fourth hypothesis was supported as well. Given that there was an extremely
low amount of p-cresol present in the blood of the participants, if any, no correlations with the
threshold test could exist. The molecules tryptophan, tyrosine, and phenylalanine were all found
in the blood samples of the participants. All of these molecules share the characteristic of a
benzene ring with p-cresol. These molecules may play a role in metabolic mechanisms that form
uremic toxins.
Vanillin and p-cresol thresholds were not found to be significantly related. One
explanation for this finding is that vanillin and p-cresol are not similar enough. Even though they
are both hydrophobic and share the characteristic of a benzene ring, they differ in molecular
weight and chemical formula. Other reasons include familiarity and hedonic qualities of the
odorants. The smell of vanilla is one of the most common odors to which people are exposed.
The odor is typically described as sweet and pleasant which could possibly influence its
detection. Because the participants are familiar with the odor, it may be easier to detect. P-cresol
is the opposite, often described by the participants as unfamiliar. If the participants are unfamiliar
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with the odor, they may have detected the lower concentrations of p-cresol in the tubes during
the threshold test, but doubted themselves because they were not familiar with it.
The third hypothesis also was not supported. One possible explanation would be the
presentation of the two tubes. The interval between the presentations of the two tubes could have
been too long, which could be corrected by using a machine rather than manual presentation.
Also, some participants attempted to pull away from smelling the p-cresol tube due to its
unpleasant odor. This may have caused the participants to inhale very little p-cresol, increasing
the certainty that they would detect vanillin. Another possibility is that p-cresol and vanillin do
not use the same OBPs for transport. There may be different OBPs that are specific towards
certain odorants and the two odorants do not use the same ones, relating back to the previous
argument that they are not completely similar molecules.
One interesting finding for the threshold test was the lack of significant gender
differences in threshold values. As noted by Doty and Cameron (2009), previous research has
found gender differences in olfactory function. Women have performed better than men,
especially at older ages, on olfactory identification tests (Doty & Cameron, 2009). There were no
differences in gender performance in this study, possibly due to the fact that it is a sensitivity
rather than identification test. Women may perform better than men on identification tests due to
a better verbal memory rather than actual odor memory. Another reason there may have been no
significant interaction of gender on threshold values would be due to age. Women and men
perform roughly the same on olfactory identification tests at younger ages. The difference
between the genders is not drastic until around the mid-30s to 40s (Doty & Cameron, 2009). In
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addition to these reasons, the small sample size may have prevented any significant differences
from being detected.
Although the study focused predominately on vanillin and p-cresol, the results showed a
positive correlation between vanillin and ethanol threshold values. Although the relationship is
positive, ethanol threshold values were very sporadic. One possibility for this wide distribution
of scores would be due to ethanol being hydrophilic. Theoretically, hydrophilic molecules would
use a different mechanism of transport to the olfactory epithelium rather than OBPs which
transport hydrophobic molecules. This different mechanism of transport may contribute to the
wide range of values. Because there is a wide range of scores, caution must be taken when
interpreting the relationship between vanillin and ethanol scores.
Another interesting finding was the relationship between isoamyl acetate and the number
of blanks. Since the relationship was negative, it would indicate that the higher the threshold
score for isoamyl acetate (worse sensitivity), the fewer blanks a participant would hit. This
would indicate that the participant who cannot detect banana would do better on the threshold
test because he/she would not respond with a “yes” in tubes that contained no odorant. This
finding does not make sense in that participants who had lower thresholds, and thus better ability
to smell, would be thought to also respond correctly at responding “no” to tubes with no
odorants. The only way this result would make sense is if the person were responding with
certainty rather than guessing. In this case, blanks may represent a measure of response bias.
This finding is contrary to expected results and thus needs to be further investigated in future
studies.
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Additional results from the threshold test were also interesting. Seasonal allergies,
asthma, and sinus problems have the potential of influencing olfactory function. Significant
interactions were expected just based on this idea, but none were found. The small sample size
could have accounted for non-significance. Future studies need to include more people with
medical conditions such as seasonal allergies, asthma, and sinus problems to get a definitive
result of the effect of medical conditions on threshold values.

Limitations and Directions for Future Research
This pilot study is limited in several ways. The first limitation is the small sample size.
Only 15 participants were recruited, and thus the study is not generalizable. The nature of the
study made it difficult to recruit participants. In order to donate blood, participants were told
what days they were able to donate, and had the option to go to Blood Assurance from 9 A.M. to
5 P.M. Around 70 participants completed the blood donation portion of the study. The limiting
factor was the threshold test. Although participants were able to choose dates and times on a
sign-up sheet to participate in the threshold test, they did not always show up. This could have
been a result of the participants forgetting the date and time they signed up for, or not wanting to
participate any further due to the extra time commitment. Also, the threshold test itself took 45
minutes, limiting the number of times offered throughout the day for participants to sign-up.
Only six slots were open on any day and combined with participants not showing up, roughly
five people a week would participate. If the threshold test was offered at any time throughout the
day, the sample size could have been larger.
The small sample size also limited the ability to obtain powerful statistical results. There
were no significant interactions between any of the medical conditions and threshold values.
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Future studies should attempt to recruit more participants and, if possible, people specifically in
those medical categories to look at the differences in olfactory sensitivity. Future studies can also
examine the specific relationship of seasonal allergies to threshold values by determining the
pollen count in the area the study is conducted.
Another limitation was the shelf life of the threshold test. After the fifteenth participant,
the researchers noticed that the odorants in some of the tubes were beginning to fade, throwing
off the concentrations. This was not expected to occur since the pilot threshold test did not fade
as quickly. One reason this may have occurred would be the continuous use of the test
throughout the day as well as the double presentation of each tube. This would cause the tubes to
be open for a longer period of time, exposing the odors to external contaminants for longer
periods of time. A few participants would also move their nose towards the tubes and breathe
into the tubes. This could affect the tubes by exposing contaminants and distorting the odorants.
Future studies should take this into account when deciding how often to remake the threshold
test.
In addition to the threshold test, there were limitations in the presentation of the vanillin
and p-cresol tubes. The first limitation was the delay between the presentation of p-cresol and
vanillin. To date, there have been no studies investigating the possible ability of p-cresol to block
detection of vanillin; thus there are no validated procedures. Although the researchers attempted
to switch the presentation of the tubes as quickly as possible, there is no way of telling if the pcresol had already been transported to the epithelium. Also, it was difficult for the researcher to
exactly record the time it took to switch the p-cresol and vanillin tubes, so replication of this
portion of the study would be difficult.
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Future studies need to present both vanillin and p-cresol first. Throughout the study, pcresol was always the first tube presented followed by vanillin. In order to support the idea that
p-cresol blocks odorants, vanillin would also have to be presented first. P-cresol is not a common
odorant and does not have a specific smell that people would be able to easily identify. Because
it was difficult to give p-cresol another name which people would recognize, it was not presented
second. Future studies may want to conduct studies on just naming p-cresol in order to get a
commonly agreed upon descriptive label.
In addition to vanillin, other odorants need to be used. Although vanillin is similar in
structure to p-cresol, it is not similar in molecular weight. Odorants that are similar to p-cresol in
weight need to be investigated. Also, odorants that are hydrophilic need to be used in future
studies in order to provide support that p-cresol takes up OBPs. If p-cresol also blocks the
detection of hydrophilic odorants, OBPs may not be the only structures of olfaction that p-cresol
affects.
Another limitation of the study was the blood analysis. The researchers only investigated
the presence of free p-cresol and not protein bound p-cresol. Studies involving p-cresol in the
ESRD population look for both types of p-cresol. Although the absence of free p-cresol would
indicate that bound p-cresol is unlikely present in the blood of healthy participants, it still should
not be ruled out. Because researchers are not sure if bound or free p-cresol is the cause of
olfactory dysfunction in the ESRD population, both types of p-cresol should be examined.
Although depression is a comorbidity in the ESRD population, a limitation of this study
was that no depression measure was used. Since depression has been studied in relation to
olfaction, futures studies need to include a depression measure. Future studies also need to
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examine the relationship between the number of comorbidities a person may have and scores on
a threshold test because uremic toxins may also play a role in comorbidities in the ESRD
population, especially diabetes and depression which have both been investigated with olfaction.
Hunger also needs to be taken into account in future studies. Because insulin levels have
been tied to olfactory function, a question regarding the last time a participant ate can be added
to the demographics questionnaire.

Conclusion
This pilot study is the first to date to examine the relationship of p-cresol to olfactory
function in healthy participants. Although there are many limitations to the study, there are also
strengths. First, the study involved the interdisciplinary effort of the psychology and chemistry
department. Prior studies involving the ESRD population have not combined the two disciplines.
Future studies will benefit from increased interdisciplinary efforts in order to explore topics that
are too complex for a single discipline.
Another strength of the study is that it supports the idea that p-cresol is not present in the
healthy population. As discussed, the ESRD population suffers from olfactory dysfunction, but
few studies have focused on the causes. Even though this pilot study has a small sample size, it is
the beginning of multiple studies involving olfaction in the ESRD population. Future studies can
replicate the study with larger sample sizes to further confirm the nonexistence of p-cresol in
healthy participants, strengthening the idea that p-cresol is the cause of olfactory dysfunction in
the ESRD population. Future studies involving olfaction and ESRD need to include p-cresol in
olfaction tests in order to strengthen this argument.
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APPENDIX A
INFORMED CONSENT (BLOOD DONATION)
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INFORMED CONSENT FORM
Presence of P-cresol in the General Healthy Population
Please read this consent document carefully before you decide to participate in this study. This
research has been approved by the University Institutional Review Board.
Purpose of the research study: The purpose is to determine the levels of p-cresol in the blood
samples.
What you will be asked to do in the study:
You will be asked to provide a sample of blood that will be stored for later use in the
determination of p-cresol levels.
Time required:
~20 minutes
Risks and Benefits:
Donors will be screened for previously diagnosed allergic response to mild volatile chemicals.
Subjects will be exposed to hypodermic needle.
Compensation:
No direct compensation will be given.
Confidentiality:
Your identity will be kept confidential to the extent provided by law. Your information will be
assigned a code number. The list connecting your name to this number will be kept in a locked
file in my research office that only I and my other research team members have access to. When
the study is completed and the data have been analyzed, the list will be destroyed. Your name
will not be used in any report.
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Voluntary participation:
Your participation in this study is completely voluntary. There is no penalty for not participating.
Right to withdraw from the study:
You have the right to withdraw from the study at anytime without consequence.

Whom to contact if you have questions about the study:
Jessica McKinney (344 Holt Hall, 931-801-4544, jessica-mckinney@mocs.utc.edu)
Dr. Manuel F. Santiago (615 McCallie Avenue, 425.5364 and Manuel-Santiago@utc.edu).
Agreement:
I have read the procedure described above. I voluntarily agree to participate in the procedure and
I have received a copy of this description.
Participant: ____________________________________ Date: _________________

If you have any questions about your rights as a subject/participant in this research, or if you feel
you have been placed at risk, you can contact Dr. Bart Weathington, Chair of the Institutional
Review Board, at 423-425-4289. Additional contact information is available at www.utc.edu/irb
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INFORMED CONSENT FORM (Threshold Test)
Odor Sensitivity and the presence of P-cresol
Please read this consent document carefully before you decide to participate in this study. This
research has been approved by the University Institutional Review Board.
Purpose of the research study: The purpose of this study is to measure odor sensitivity in healthy
adults and to see if healthy adults are able to identify two odors.
What you will be asked to do in the study:
You will initially be asked to complete a brief demographics page. A researcher will then begin
the threshold test by presenting a tube filled with clear liquid beneath your nose for 5 seconds.
After these 5 seconds have passed, you will be given 10 seconds to tell the researcher “yes”-you
did detect an odor or “no”- you did not detect an odor. The test contains 105 tubes with various
odors and concentrations, although not all of the tubes will contain odors. Finally, you will be
presented with one scratch and sniff card which you will be asked to scratch and identify the
odor and then do the same with a second scratch and sniff card.
Time required:
~50 minutes
Risks and Benefits:
You may experience some nasal dryness from prolonged smelling. We do not anticipate any
direct benefit from the study, but we do appreciate your participation as this will add to a
growing body of research that will benefit other people in the future.
Compensation:
No direct compensation will be given.
Confidentiality:
Your identity will be kept confidential to the extent provided by law. Your information will be
assigned a code number. The list connecting your name to this number will be kept in a locked
file in my research office that only I and my other research team members have access to. When
the study is completed and the data have been analyzed, the list will be destroyed. Your name
will not be used in any report.
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Voluntary participation:
Your participation in this study is completely voluntary. There is no penalty for not participating.
Right to withdraw from the study:
You have the right to withdraw from the study at any time without consequence.

Whom to contact if you have questions about the study:
Jessica McKinney (348 Holt Hall, 931-801-4544, jessica-mckinney@mocs.utc.edu)
William Tewalt (344 Holt Hall, wtewalt@gmail.com)
Hannah Tumlin (344 Holt Hall, hannah-tumlin@mocs.utc.edu)
Joseph Jones (344 Holt Hall, joseph-jones@mocs.utc.edu)
Aaron Wamsley (344 Holt Hall, aaron-wamsley@mocs.utc.edu)
Dr. Nicky Ozbek (350 Holt Hall, 425-4285 and Nicky-Ozbek@utc.edu).
Agreement:
I have read the procedure described above. I voluntarily agree to participate in the procedure and
I have received a copy of this description.
Participant: ____________________________________ Date: _________________
Print Name: ___________________________________
If you have any questions about your rights as a subject/participant in this research, or if you feel
you have been placed at risk, you can contact Dr. Bart Weathington, Chair of the Institutional
Review Board, at 423-425-4289. Additional contact information is available at www.utc.edu/irb
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Age (in years): _________
Gender (circle one);

Male

Female

If female, please answer the questions located on the next page. ***
Ethnicity (circle one):

Caucasian

Bi-Racial

African American

Asian American

Hispanic

Other (please indicate): _______________________________

Do you currently smoke (circle one):

Yes

No

Yes

No

If yes; How many cigarettes per day?_____; Cigars per day?____
What type of cigarettes do you smoke? __________________________
How many years have you smoked? ______________
If not currently smoking, have you ever smoked? (Circle one):
If yes, how long ago did you stop?_______
How many cigarettes did you smoke per day?_____; Cigars per day?_____
Did your ability to smell change after you stopped smoking? (Circle one):

Yes

No

If yes; How?
_____________________________________________________________________________________
_____________________________________________________________________________________

What is your occupation: ____________________________________________________
Highest grade completed? (Circle only one number):
6

7

8

9

10

11

12 College 1

2

3

4

5

+

Please indicate if you have had past history of the following medical Illnesses. (Circle Yes or No):
High blood pressure

Yes

No

Diabetes

Yes

No

Arthritis

Yes

No

Heart disease

Yes

No

Thyroid disorder

Yes

No

Headaches

Yes

No

Lung trouble

Yes

No

Gout

Yes

No

Epilepsy

Yes

No

Circulation problems

Yes

No

Broken nose

Yes

No

Anemia

Yes

No

Strokes

Yes

No

Eye problems

Yes

No
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Asthma

Yes

No

Cancer

Yes

No

Please indicate if you have had past history of the following medical Illnesses. (Circle Yes or No):
Hepatitis

Yes

No

Ulcer

Yes

No

Hiatal hernia

Yes

No

Kidney disease

Yes

No

Pelvic disease

Yes

No

Skin disease

Yes

No

Prostate problems

Yes

No

Infections

Yes

No

Bleeding/clotting disorder

Yes

No

HIV

Yes

No

TB

Yes

No

Neurological disease

Yes

No

Deviated septum

Yes

No

Sinus problems

Yes

No

Concussion/head trauma

Yes

No

Medical allergies

Yes

No

Food allergies

Yes

No

Seasonal allergies

Yes

No

Other: _______________________________________________________________________________
Please indicate if you are currently taking any of the following types of medications. (Circle Yes or
No):
Antibiotics

Yes

No

Antidepressants

Yes

No

Hormone replacements

Yes

No

Antihistamines

Yes

No

Antihypertensive

Yes

No

Antianxiety

Yes

No

Lithium

Yes

No

Anti-inflammatory†

Yes

No

Yes

No

†

Including ibuprofen

Antineoplastic††
††

Examples of Antineoplastics are Elspar (asparaginase), Alkeran (melphalan), floxuridine,
lomustine, procarbazine, thioguanine, thiotepa
Stimulant medications†††
†††

Yes

No

Examples of Stimulant medications are Adderall and Vyvanse

Have you ever been diagnosed with Sleep Apnea? (Circle one):

Yes

***Females (optional, But VERY BENEFICIAL to answering research questions)
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No

If FEMALE; Are you currently on your menstrual cycle? (Circle one):

Yes

No

If FEMALE; Are you currently pregnant? (Circle one):

Yes

No

If FEMALE; Are you in menopause or post menopause? (Circle one):

Yes

No
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VANILLIN

P-CRESOL
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Blood samples were collected by Blood Assurance and refrigerated at 4 degrees Celsius
immediately after collection until filtration. One milliliter aliquots of each sample were
withdrawn using a sterilized syringe and needle and subjected to ultracentrifugation in a
Centrifree Micropartition device with a 30,000 Dalton cut-off membrane at 2000xg for 30
minutes (De Smet et al., 1998). Filtrate samples containing small molecules were labeled and
kept refrigerated prior to further analysis.
Standard solutions containing single analyte molecules to be detected that were dissolved in
HPLC-grade water at varying concentrations were examined in order to verify the detection
(retention times, corresponding peak height, and mass spectra) of these molecules using the
HPLC and MS techniques described below. These included analysis of p-cresol (4 M, 104 M,
204 M, 304 M, 404 M, 504 M, 604 M, 804 M, 904 M, 1104 M, 1204 M, 1304 M,
1404 M, 1504 M, 1604 M, 1704 M, and 2300 M), vanillin (150 M, 1500 M, and 3000
M), 2-amino-p-cresol (10 M, 200 M, 600 M, 1000 M, 1400 M, and 1800 M), and
tryptophan (150 M, 1500 M, and 3010 M).
Reversed-Phase High Performance Liquid Chromatography (HPLC) with a ThermoFinnigan
UV1000 SpectraSystem HPLC was used for separation of molecular components in the filtrate
mixture. The instrument was equipped with a stationary phase 250-mm x 4.6-mm C18 column
(void volume of 2.5 mL); mobile-phase buffers used in the separation were 50mM ammonium
formate (HCO2NH4) made in HPLC-grade water (buffer A) and HPLC-grade methanol (CH3OH,
buffer B) (as described in De Smet et al. 1998). A five minute column pre-clean was performed
using methanol prior to each set of analyses, and the sample syringe was washed three times with
methanol and water between injections to avoid cross-contamination.
Filtrate samples (20μL) were loaded onto the column and subjected to elution over 18 minutes at
a flow rate of 1 mL/min by the mobile phase buffers as follows: gradient elution was initialized
at 100% HCO2NH4 / 0% CH3OH. Over the first three minutes of each run, buffer concentrations
shifted from 0-40% CH3OH; for the next ten minutes, the gradient changed from 40-75%
CH3OH; the final two minutes of each run ramped the concentration of CH3OH to 100%.
Components of filtrate samples eluting from the column were detected by ultraviolet absorbance
using a deuterium lamp at a wavelength of 280 nm. Absorbance was also monitored at a
wavelength of 214 nm, but no significant differences were observed in the elution
chromatograms compared to the profile with detection at 280 nm. Eluent fractions corresponding
to each portion of the HPLC chromatogram were collected in labeled test tubes.
Mass spectrometry (MS) experiments were performed for each sample fraction collected from
the HPLC to determine the content of the molecules contained in each, thus allowing
identification of the presence of uremic toxins. Data were collected using a ThermoFinnigan
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Polaris Q MS equipped with a Direct Probe Controller. All samples were mixed thoroughly and
the syringe cleaned three times with methanol before deposition of 6-8 L of sample onto the
probe filament. Samples were and allowed to air-dry, then heated in vacuum to remove
remaining solvent. Each experiment consisted of a temperature ramp for ballistic heating of the
filament from 0-1000 mA/sec at 200 mA/sec in order to desorb the sample into the MS source.
Samples were then held at 1000mA/s for 120 seconds, and ions were detected in the molecular
weight range of 0-300 amu in order to identify uremic toxin molecules. Immediate cleaning of
the filament was performed by the instrument after each run.
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MEMORANDUM

TO:

Jessica McKinney

IRB # 12- 149

Dr. Nicky Ozbek
FROM:

Lindsay Pardue, Director of Research Integrity
Dr. Bart Weathington, IRB Committee Chair

DATE:

October 18, 2012

SUBJECT:

IRB # 12-149: Odor Sensitivity and the presence of P-cresol

The Institutional Review Board has reviewed and approved your application and assigned you
the IRB number listed above. You must include the following approval statement on research
materials seen by participants and used in research reports:
The Institutional Review Board of the University of Tennessee at Chattanooga
(FWA00004149) has approved this research project #12-149.
Please remember that you must complete a Certification for Changes, Annual Review, or Project
Termination/Completion Form when the project is completed or provide an annual report if the
project takes over one year to complete. The IRB Committee will make every effort to remind
you prior to your anniversary date; however, it is your responsibility to ensure that this additional
step is satisfied.
Please remember to contact the IRB Committee immediately and submit a new project proposal
for review if significant changes occur in your research design or in any instruments used in
conducting the study. You should also contact the IRB Committee immediately if you encounter
any adverse effects during your project that pose a risk to your subjects.
For any additional information, please consult our web page http://www.utc.edu/irb or email
instrb@utc.edu
Best wishes for a successful research project.
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VITA

Jessica McKinney is a Tennessee native who completed her Bachelor of Science degree
at the University of Tennessee-Chattanooga in Psychology with a minor in Biology. She
originally moved to Tennessee through her father’s career in the military, which inspired her
research interest in PTSD. While at the University of Tennessee at Chattanooga, she has
presented at multiple conferences and worked with different research teams. She will be
continuing her education by pursuing a PhD in Clinical Psychology in hopes to work with the
military.
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